Skip to main content
Clinical Trials/ACTRN12608000414314
ACTRN12608000414314
Completed
Phase 4

A randomised clinical trial to compare the efficacy of pressurised vapocoolant spray and subcutaneous lignocaine injection in decreasing the pain of intravenous cannulation in the emergency department

Austin Health0 sites220 target enrollmentAugust 22, 2008

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Austin Health
Enrollment
220
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 22, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Emergency department patients, aged 18 years or more, requiring intravenous cannulation

Exclusion Criteria

  • Refusal to provide consent
  • Inability to provide informed consent (Non\-English speaking, altered mental state, significant illness, urgent need for IV cannulation)
  • Moderate to severe discomfort or pain
  • Diseases of the skin associated with cold intolerance (eg: Raynaud’s)
  • Known allergy to spray contents or lignocaine
  • Peripheral neuropathy
  • Parenteral analgesia in the previous 4 hours
  • Use of other local anaesthetics

Outcomes

Primary Outcomes

Not specified

Similar Trials